Stock 2633 JACOBSON PHARMA CORPORATION LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials Jacobson Pharma Corporation Limited

Equities

2633

KYG677291067

Pharmaceuticals

Market Closed - Hong Kong S.E.
Other stock markets
 04:08:20 2024-04-26 am EDT 		5-day change 1st Jan Change
0.56 HKD -1.75% Intraday chart for Jacobson Pharma Corporation Limited -1.75% -12.50%
Feb. 27 Jacobson Pharma Raises HK$39 Million from Share Placement MT
2023 Jacobson Pharma Reports 42% Fiscal H1 Profit Growth; Shares Rise MT

Valuation

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Capitalization 1 3,304 3,205 2,716 1,839 1,245 1,846
Enterprise Value (EV) 1 3,952 3,813 3,868 2,964 2,125 2,356
P/E ratio 16.3 x 12.3 x 13 x 10.6 x 7.01 x 7.39 x
Yield 2.09% 2.83% 3.19% 2.4% 5.97% 5.34%
Capitalization / Revenue 2.13 x 1.88 x 1.73 x 1.27 x 0.78 x 1.03 x
EV / Revenue 2.55 x 2.24 x 2.46 x 2.05 x 1.33 x 1.32 x
EV / EBITDA 10.1 x 8.36 x 9.41 x 9.88 x 5.42 x 4.84 x
EV / FCF 62 x 15.1 x 29.5 x 11.4 x 7.45 x 5.5 x
FCF Yield 1.61% 6.62% 3.39% 8.77% 13.4% 18.2%
Price to Book 1.67 x 1.21 x 1.07 x 0.77 x 0.5 x 0.68 x
Nbr of stocks (in thousands) 1,815,625 2,015,625 1,926,521 1,915,677 1,915,677 1,902,921
Reference price 2 1.820 1.590 1.410 0.9600 0.6500 0.9700
Announcement Date 7/26/18 7/24/19 7/21/20 7/22/21 7/27/22 7/7/23
1HKD in Million2HKD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net sales 1 1,549 1,705 1,571 1,446 1,596 1,786
EBITDA 1 389.5 456 411.1 299.9 391.8 487.1
EBIT 1 280.1 344.7 303.6 164.3 248.5 350.1
Operating Margin 18.09% 20.22% 19.32% 11.36% 15.57% 19.61%
Earnings before Tax (EBT) 1 251.2 315.1 263.5 220.6 231.4 339.8
Net income 1 202.3 250.6 215.6 173.7 177.7 251
Net margin 13.06% 14.7% 13.72% 12.01% 11.14% 14.06%
EPS 2 0.1114 0.1298 0.1087 0.0907 0.0927 0.1313
Free Cash Flow 1 63.75 252.3 131.3 260 285.4 428.3
FCF margin 4.12% 14.8% 8.35% 17.98% 17.88% 23.99%
FCF Conversion (EBITDA) 16.37% 55.32% 31.93% 86.69% 72.84% 87.93%
FCF Conversion (Net income) 31.52% 100.68% 60.87% 149.66% 160.61% 170.62%
Dividend per Share 2 0.0380 0.0450 0.0450 0.0230 0.0388 0.0518
Announcement Date 7/26/18 7/24/19 7/21/20 7/22/21 7/27/22 7/7/23
1HKD in Million2HKD
Estimates

Balance Sheet Analysis

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net Debt 1 647 608 1,152 1,125 880 511
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) 1.662 x 1.333 x 2.802 x 3.752 x 2.246 x 1.048 x
Free Cash Flow 1 63.8 252 131 260 285 428
ROE (net income / shareholders' equity) 10.8% 11% 8.22% 6.82% 6.45% 9.11%
ROA (Net income/ Total Assets) 5.32% 5.47% 4.29% 2.17% 3.23% 4.32%
Assets 1 3,802 4,578 5,024 7,990 5,505 5,815
Book Value Per Share 2 1.090 1.310 1.320 1.250 1.300 1.430
Cash Flow per Share 2 0.3600 0.3100 0.2200 0.2500 0.2500 0.5400
Capex 1 86.9 44.1 84.4 63.4 63.9 63
Capex / Sales 5.61% 2.59% 5.37% 4.38% 4% 3.53%
Announcement Date 7/26/18 7/24/19 7/21/20 7/22/21 7/27/22 7/7/23
1HKD in Million2HKD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Annual profits - Rate of surprise

Company calendar

Sector Generic Pharmaceuticals

1st Jan change Capi.
JACOBSON PHARMA CORPORATION LIMITED Stock Jacobson Pharma Corporation Limited
-12.50% 143M
SUN PHARMACEUTICAL INDUSTRIES LTD. Stock Sun Pharmaceutical Industries Ltd.
+19.62% 43.34B
OTSUKA HOLDINGS CO., LTD. Stock Otsuka Holdings Co., Ltd.
+20.44% 21.96B
SANDOZ GROUP AG Stock Sandoz Group AG
+10.86% 14.09B
CIPLA LIMITED Stock Cipla Limited
+13.07% 13.64B
ZYDUS LIFESCIENCES LIMITED Stock Zydus Lifesciences Limited
+37.46% 11.43B
ONO PHARMACEUTICAL CO., LTD. Stock Ono Pharmaceutical Co., Ltd.
-8.59% 6.86B
THE MEDICINES COMPANY Stock The Medicines Company
-0.05% 6.79B
STADA ARZNEIMITTEL Stock STADA Arzneimittel
-8.87% 5.73B
ASPEN PHARMACARE HOLDINGS LIMITED Stock Aspen Pharmacare Holdings Limited
+8.46% 5.22B
Generic Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 2633 Stock
  4. Financials Jacobson Pharma Corporation Limited